<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180711040419N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-10-11</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of kinesiotaping on jump height and agility</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of faciliatory kinesiotaping technique on latent trigger points of the Quadriceps and Gastrocnemius muscles on jump height and agility in Volleyball and Basketball players: A randomized clinical trial study</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-10-07</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>44</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/85803</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: For randomization and allocation of participants into the intervention and control groups, block randomization with 11 blocks, each consisting of 4 participants, will be used. Accordingly, 44 eligible volunteers will be randomly selected from the study population. Using the Random Allocation Software, which generates a random sequence of groups A and B, participants will be assigned to either the intervention or control group. Group A will be labeled as the facilitation kinesio taping group and Group B as the sham kinesio taping group. Participants will be allocated to one of the two groups in the order of their enrollment, based on the generated randomization list, Blinding description: The study participants will not be aware of whether they are assigned to the intervention or control group, since kinesiotaping is applied to the same muscles in both groups and the participants are not informed about the technique or the purpose of the kinesiotaping application. In addition, the assessor will also be blinded to the group allocation of the participants.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Presence of latent trigger points.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Before the application of kinesio tape, participants are asked to shave the hair on the anterior thigh and posterior calf to avoid any interference with the application and effectiveness of the tape. In addition, prior to taping, the skin is thoroughly cleaned with alcohol and then dried. Throughout the study, kinesio tape of the brand Ares, Extreme model, 5 cm width, manufactured in South Korea is used. For the Intervention group, facilitation kinesio taping is applied to the latent trigger points of the quadriceps and gastrocnemius muscles of both lower limbs. The muscle containing the latent trigger point is placed in its lengthened position, and an 8 cm facilitation kinesio tape is applied over the trigger point. Specifically, 2 cm above the point the tape is applied without tension, then with 50% tension directly over the trigger point, and finally 2 cm below the point without tension. Quadriceps muscle – application of facilitation kinesio taping on the latent trigger point: The participant lies in a supine position on the bed, with the leg hanging off the edge so that the muscle is in its lengthened position. Facilitation kinesio tape with 50% tension is applied in the direction of the muscle fibers, from origin to insertion, over the latent trigger point. The edges of each tape strip are rounded before application. Gastrocnemius muscle – application of facilitation kinesio taping on the latent trigger point: For taping the gastro-soleus muscle, the participant lies in the prone position on the bed, with the foot extending off the edge. Then, by performing dorsiflexion to place the muscle in its lengthened position, facilitation kinesio tape with 50% tension is applied in the direction of the muscle fibers, from origin to insertion, over the latent trigger point. The edges of each tape strip are rounded before application. The kinesiotape is applied once for each participant and remains on the tissue for 24 hours. Intervention 2: Control group: Before the application of kinesio tape, participants are asked to shave the hair on the anterior thigh and posterior calf to avoid any interference with the application and effectiveness of the tape. In addition, prior to taping, the skin is thoroughly cleaned with alcohol and then dried. Throughout the study, kinesio tape of the brand Ares, Extreme model, 5 cm width, manufactured in South Korea is used. For the Control group, Sham kinesio taping is applied to the latent trigger points of the quadriceps and gastrocnemius muscles of both lower limbs. The kinesio tape is cut to a length equal to one-third of the circumference of the patient’s thigh or calf at the trigger point site. For the sham group, after identifying the trigger point, the tape is applied without any tension, while the muscle remains in its neutral length, placed horizontally and perpendicular to the muscle fibers. First, the center of the tape is adhered, followed by the edges (61, 77, 78). The kinesio tape remains in place for 24 hours, after which the athlete returns for tape removal and reassessment. Quadriceps muscle – application of sham kinesio taping on the latent trigger point: For this purpose, an I-shaped kinesio tape strip is used. The participant sits on the bed; after removing the backing paper, the tape is applied horizontally over the latent trigger point of the quadriceps muscle without any tension. The center of the tape is adhered first, followed by the edges. The corners of each strip are rounded before application (61, 77).Gastrocnemius muscle – application of sham kinesio taping on the latent trigger point: The participant lies in a prone position with the foot in neutral. An I-shaped kinesio tape strip is applied horizontally, without tension, over the latent trigger point of the gastrocnemius muscle. First, the center of the tape is adhered, followed by both ends. The corners of each strip are rounded before application (77, 88).The kinesiotape is applied once for each participant and remains on the tissue for 24 hours.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Information collection form including primary outcomes, informed consent form and SPSS file

When:
After publication the results of the study

To whom:
Researchers working in academic and scientific institutions

Conditions:
Only for recording information in scientific databases

Where to obtain:
Correspondence with the project manager by email. rezaeik@sums.ac.ir

How to obtain:
Maximum one month after sending the request by email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Katayoon Rezaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation Sciences, Shahid Doran Campus, After Amir-al-Momenin Burn Accident Hospital, Sadra Town Road</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7198754361</zip>
        <telephone>+98 71 3212 2600</telephone>
        <email>rezaeik@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Katayoon Rezaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation Sciences, Shahid Doran Campus, After Amir-al-Momenin Burn Accident Hospital, Sadra Town Road</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7198754361</zip>
        <telephone>+98 71 3212 2600</telephone>
        <email>rezaeik@sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Male gender.
Participation in at least one 2-hour volleyball or basketball training session or match per week, or two 1-hour sessions per week, during the last 2 years.
Age between 18 and 35 years.
Presence of at least one latent myofascial trigger point in the quadriceps and gastrocnemius muscles of both lower limbs</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>35 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>The presence of musculoskeletal problems (such as pain in the lower limbs) that prevent the individual from performing the tests.
Lack of willingness to participate in the study.
trauma or injury to the lower limb muscles or joints within the last 6 months that resulted in at least 2 weeks of absence from activity, or in which the athlete still experiences pain.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Before the application of kinesio tape, participants are asked to shave the hair on the anterior thigh and posterior calf to avoid any interference with the application and effectiveness of the tape. In addition, prior to taping, the skin is thoroughly cleaned with alcohol and then dried. Throughout the study, kinesio tape of the brand Ares, Extreme model, 5 cm width, manufactured in South Korea is used. For the Intervention group, facilitation kinesio taping is applied to the latent trigger points of the quadriceps and gastrocnemius muscles of both lower limbs. The muscle containing the latent trigger point is placed in its lengthened position, and an 8 cm facilitation kinesio tape is applied over the trigger point. Specifically, 2 cm above the point the tape is applied without tension, then with 50% tension directly over the trigger point, and finally 2 cm below the point without tension. Quadriceps muscle – application of facilitation kinesio taping on the latent trigger point: The participant lies in a supine position on the bed, with the leg hanging off the edge so that the muscle is in its lengthened position. Facilitation kinesio tape with 50% tension is applied in the direction of the muscle fibers, from origin to insertion, over the latent trigger point. The edges of each tape strip are rounded before application. Gastrocnemius muscle – application of facilitation kinesio taping on the latent trigger point: For taping the gastro-soleus muscle, the participant lies in the prone position on the bed, with the foot extending off the edge. Then, by performing dorsiflexion to place the muscle in its lengthened position, facilitation kinesio tape with 50% tension is applied in the direction of the muscle fibers, from origin to insertion, over the latent trigger point. The edges of each tape strip are rounded before application. The kinesiotape is applied once for each participant and remains on the tissue for 24 hours.</i_keyword>
      <i_keyword>Control group: Before the application of kinesio tape, participants are asked to shave the hair on the anterior thigh and posterior calf to avoid any interference with the application and effectiveness of the tape. In addition, prior to taping, the skin is thoroughly cleaned with alcohol and then dried. Throughout the study, kinesio tape of the brand Ares, Extreme model, 5 cm width, manufactured in South Korea is used. For the Control group, Sham kinesio taping is applied to the latent trigger points of the quadriceps and gastrocnemius muscles of both lower limbs. The kinesio tape is cut to a length equal to one-third of the circumference of the patient’s thigh or calf at the trigger point site. For the sham group, after identifying the trigger point, the tape is applied without any tension, while the muscle remains in its neutral length, placed horizontally and perpendicular to the muscle fibers. First, the center of the tape is adhered, followed by the edges (61, 77, 78). The kinesio tape remains in place for 24 hours, after which the athlete returns for tape removal and reassessment. Quadriceps muscle – application of sham kinesio taping on the latent trigger point: For this purpose, an I-shaped kinesio tape strip is used. The participant sits on the bed; after removing the backing paper, the tape is applied horizontally over the latent trigger point of the quadriceps muscle without any tension. The center of the tape is adhered first, followed by the edges. The corners of each strip are rounded before application (61, 77).Gastrocnemius muscle – application of sham kinesio taping on the latent trigger point: The participant lies in a prone position with the foot in neutral. An I-shaped kinesio tape strip is applied horizontally, without tension, over the latent trigger point of the gastrocnemius muscle. First, the center of the tape is adhered, followed by both ends. The corners of each strip are rounded before application (77, 88).The kinesiotape is applied once for each participant and remains on the tissue for 24 hours.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Jump Height: The maximum distance of the individual from the ground after jumping off the surface. Timepoint: 1. Before the intervention 2. 24 hours after the intervention. Method of measurement: Measuring tape.</prim_outcome>
      <prim_outcome>T-test sprint time: The duration it takes for the participant to complete the designated course and cross the finish line. Timepoint: 1. Before the intervention 2. 24 hours after the intervention. Method of measurement: Stopwatch.</prim_outcome>
      <prim_outcome>Pressure pain threshold (PPT): The minimum amount of pressure that elicits an unpleasant pain sensation in the participant, measured using a pressure algometer. Timepoint: 1. Before the intervention 2. 24 hours after the intervention. Method of measurement: Pressure algometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-07-30</approval_date>
        <contact_name>Research Ethics Committees of Shiraz School of Rehabilitation Sciences</contact_name>
        <contact_address>Sadra City Road,after Amir al-Momenin (AS) Burn Injuries Hospital, Shahid Doran Campus, Faculty of Rehabilitation Sciences shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
